Encube Ethicals’ Post

Interesting news from India.

What's Buzzing At The Dealers' Desk? D-Street is abuzz with interesting developments at Piramal Pharma, GNFC, Kesoram Industries, ITD Cem. Nimesh Shah brings you the key insights #DStreet #PiramalPharma #GNFC #KesoramIndustries #ITDCem #businessnews #businessnewstoday #businessnewsinenglish

🌈𝐁𝐚𝐢𝐧 𝐝𝐢𝐚𝐥𝐬 𝐃𝐫 𝐑𝐞𝐝𝐝𝐲'𝐬 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐢𝐞𝐬 𝐭𝐨 𝐭𝐞𝐚𝐦 𝐮𝐩 𝐟𝐨𝐫 𝐣𝐨𝐢𝐧𝐭 𝐂𝐢𝐩𝐥𝐚 𝐛𝐢𝐝 🍁Private equity firm Bain Capital has approached Indian pharmaceutical company Dr Reddy's Laboratories (DRL) to explore a joint bid for the promoters of Cipla, the Hamied family. 🍁DRL is evaluating the opportunity and countering an offer from Torrent Pharma, another Indian investor. If DRL decides to participate, the combined entity would become the leading Indian-origin pharma major at home and in the US and emerging markets. 🍁US buyout group Bain Capital has approached Dr Reddy's Laboratories (DRL) to explore a joint bid to buy out the promoters of Cipla, the Hamied family. 🍁Last week, senior leadership from both sides met along with their advisors to discuss and formalize a strategy, said people aware of the development. Source: Indiatimes #pharma #pharmaceuticalindustry

🚀 Big news alert! 🚀 Cipla promoters are set to sell 2.5% stake for a whopping Rs 2,650 crore! 💰 This strategic move by the company's founders is an exciting development for the pharma industry and signals strong confidence in the company's growth trajectory. 🌟 This step not only reflects the robust performance and potential of Cipla but also underlines the promoters' belief in the company's long-term vision! 📈 It's all about seizing the opportunities to fuel future growth and innovation. 🌍 #Cipla #PharmaIndustry #BusinessNews #Investment #GrowthStrategy What are your thoughts on this move? Share your insights in the comments! 🤔 Let's spark a meaningful conversation about this significant development in the pharmaceutical sector! 🙌 Note: AI-powered post. May contain errors.

Epic saga of Cipla: How a swadeshi Robin Hood took on Big Pharma of the West https://lnkd.in/g8c7vkxn Download Economic Times App to stay updated with Business News - https://lnkd.in/gaCpGx9h An interesting story of Cipla Pharma, which made India as one of the giants and saviour of developing countries.,

Featured in India Today for 'India's Most Admired and Trusted Brands,' Murli Krishna Pharma Pvt. Ltd continues to shine as a leading manufacturer of Pre-Finished Formulation Intermediates and Finished Dosage forms. The company's products hold approvals from prestigious bodies such as the European Union, WHO, GCC, and Jordanian FDA, underscoring their commitment to quality and compliance. MKPPL specializes in producing Pellets & Micro Pellets as part of its product range, while also employing Micro and Nano emulsions in the manufacturing of Finished Dosage Forms. Their innovative approach includes an aqueous pathway that leads to patient-friendly solutions and a solvent-free manufacturing process, ensuring high quality products offered at affordable rates. Dr. Satya Vadlamani, CMD of Murli Krishna Pharma, provides insights into the company's vision, missions, and the dedication to delivering high-quality products. With a focus on innovation and quality, Murli Krishna Pharma stands out as a trusted name in the pharmaceutical industry. Watch & Listen for More: https://lnkd.in/dzQWdhZ8 --- #MurliKrishnaPharma #PharmaceuticalIndustry #HealthcareExcellence #QualityProducts #InnovativeSolutions #TrustedBrands #PatientFriendly #PharmaManufacturing #ResearchAndDevelopment #GMPCompliance #HealthcareInnovation #GlobalPharma #AwardWinning #LeadersInPharma #HealthAndWellBeing #PharmaLeaders #QualityDriven #HealthcareHeroes #PharmaInnovation #GlobalRecognition

JB Pharma aims to grow by 12-14% in the next 2 years. Day #61 💊JB Pharma in the news buzz.! Mumbai based JB Pharma is aiming to grow its revenue by 12-14 per cent in the next two years. 💊How do they plan to do.? The company is particularly focused on expanding its presence in the chronic medicines segment and its contract development and manufacturing organization (CDMO) business. 💊Who and all have they tied up with.? JB Pharma partners with top international players like Reckitt, P&G, J&J, and Inova to manufacture cough and cold lozenges. 💊Where are they planning to expand.? The company is planning to expand towards Europe and Brazil through tie-ups and product launches. I will provide the source of the article in the comment section below. By the way today is the 61st day of me deep diving into the pharmaceutical industry. I will be sharing insights from this industry on a regular basis. So please do follow me (Krishna Raj K) for such insights. #finance #Linkedin #India

Third Party Manufacturing in Baddi Wish to invest in the pharma segment in Baddi? Avail exciting business prospects in our Third Party Manufacturing in Baddi, fast emerging as the hub of pharma industries in Himachal Pradesh. Baddi is advantageous in offering the pharmaceutical business as it is equipped with a good infrastructure, tax holidays, and a qualified personnel.  Besides, Baddi's Third Party Manufacturing in Baddi has embraced structural measures that give easier and quicker access to regulatory mechanisms as well as, comply with laid down guidelines. This regulatory support reduces the business obstacles, thus enabling pharma franchises to concentrate on value addition, high-quality product development, and market penetration. https://qr.ae/psE9ue

We are supremely elated to have participated in the 62nd Anniversary celebrations of Indian Drug Manufacturers' Association and #Vriddhi - an exceptional platform dedicated to elevating, accelerating, and growing the Indian Pharmaceutical industry. At #Vriddhi, we had the invaluable opportunity to learn and engage with some of the brightest minds and thought leaders in the industry. Over the course of two enriching days, we delved into myraid of topics from insights into emerging markets and digitization-Pharma 4.0 to perspectives on quality, regulations, and pharmaceutical corporate finance strategies. The sessions went beyond the drugs, exploring the nuances of persuasion, importance of values in value creation and succession planning; the vital pillars for sustained organizational growth aimed towards realizing vision 2030 for the Indian pharmaceutical industry. We take immense pride in our role within the Indian Pharmaceutical industry, persistently striving to introduce innovative solutions as India continues its odyssey to thrive, innovate, and lead on the global stage. Cheers to growth, innovation, and collaboration while we cure, heal and rejuvenate 🥂 #Spinco #Vriddhi2024 #Indianpharma #IDMA #pharmaceuticalindustry #pharmaceuticalmanufacturing #Amritkaal #India #solutionprovider #Customerization #innovation #growth #leadership